Thromboprophylaxis for children hospitalized with COVID‐19 and MIS

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves - ScienceDirect

Current practices in pediatric hospital‐acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium - Research and Practice in Thrombosis and Haemostasis

Pathogens, Free Full-Text

Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19

Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium - eClinicalMedicine

SciELO - Brasil - Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2 Proposed recommendations for antithrombotic prophylaxis for

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID -19 — COVID-NET, 14 States, March 2020–February 2022

Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry - ScienceDirect